Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Cancer
|
August 8, 2013
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project
Andrew M Evens, Ann Vanderplas, Ann S LaCasce, et al.
Leukemia & Lymphoma
|
March 16, 2013
Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma
Bouthaina S Dabaja, Jack Phan, Osama Mawlawi, et al.
British Journal of Haematology
|
December 10, 2015
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
Dai Chihara, Chan Y Cheah, Jason R Westin, et al.
Blood
|
January 12, 2012
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database
Ann S LaCasce, Jonathan L Vandergrift, Maria A Rodriguez, et al.
British Journal of Haematology
|
October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database
Makiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Cancer
|
April 8, 2014
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network
Alex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, et al.
Kidney International Reports
|
September 21, 2020
Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure
Takayuki Yamada, Hiroki Ueyama, Nitin Chopra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 5, 2016
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex
Zheng Zhou, Alfred W Rademaker, Leo I Gordon, et al.
British Journal of Haematology
|
March 25, 2017
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study
Loretta J Nastoupil, Peter McLaughlin, Lei Feng, et al.
JAMA Oncology
|
July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial
Chelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Cancer
|
August 8, 2013
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project
Andrew M Evens, Ann Vanderplas, Ann S LaCasce, et al.
Leukemia & Lymphoma
|
March 16, 2013
Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma
Bouthaina S Dabaja, Jack Phan, Osama Mawlawi, et al.
British Journal of Haematology
|
December 10, 2015
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
Dai Chihara, Chan Y Cheah, Jason R Westin, et al.
Blood
|
January 12, 2012
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database
Ann S LaCasce, Jonathan L Vandergrift, Maria A Rodriguez, et al.
British Journal of Haematology
|
October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database
Makiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Cancer
|
April 8, 2014
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network
Alex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, et al.
Kidney International Reports
|
September 21, 2020
Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure
Takayuki Yamada, Hiroki Ueyama, Nitin Chopra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 5, 2016
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex
Zheng Zhou, Alfred W Rademaker, Leo I Gordon, et al.
British Journal of Haematology
|
March 25, 2017
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study
Loretta J Nastoupil, Peter McLaughlin, Lei Feng, et al.
JAMA Oncology
|
July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial
Chelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Page
of 8